Fresenius Medical Care AG/€FME

05:30
15:10
00:45
10:25
20:00
1D1W1MYTD1Y5YMAX

About Fresenius Medical Care AG

Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.

Ticker

€FME
Sector

Primary listing

XETRA

Employees

112,445

FME Metrics

BasicAdvanced
€13B
19.65
€2.23
0.86
€1.44
3.29%

What the Analysts think about FME

Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.

Bulls say / Bears say

Revenues rose 5% year-on-year to €4.79 billion in Q2, slightly exceeding market expectations and showing steady demand for services (Reuters).
The FME25 transformation program delivered €58 million in cost savings in Q2, driving operational efficiency and supporting higher margins (Reuters).
The launch of a €1 billion share buyback signals strong free cash flow and confidence from management in the company’s long-term outlook (Reuters).
Adjusted operating income rose to €476 million in Q2 but missed the €492 million analysts had expected, indicating pressure on operating margins (Reuters).
U.S. same-market treatment growth was flat in Q2, as a severe flu season increased patient mortality and reduced treatment numbers, leading Fresenius to lower its full-year U.S. growth outlook from above 0.5% to flat or slightly positive (Reuters).
Shares fell 4% after the Q2 results and revised guidance, showing investor worries about the company’s short-term growth prospects (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2025.

FME Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

FME Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €FME

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs